[Internal treatment of carcinoma with the cytostatic Proresid].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D007680:Kidney Neoplasms / Q000188:drug therapy; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008875:Middle Aged; D009362:Neoplasm Metastasis / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy*; D010051:Ovarian Neoplasms / Q000188:drug therapy; D010534:Peritoneal Neoplasms / Q000188:drug therapy; D010538:Peritonitis / Q000188:drug therapy; D008517:Phytotherapy; D010946:Plants, Medicinal; D010947:Plants, Toxic; D010997:Pleural Neoplasms / Q000188:drug therapy; D010998:Pleurisy / Q000188:drug therapy; D011035:Podophyllum / Q000627:therapeutic use*; D013274:Stomach Neoplasms / Q000188:drug therapy; D014594:Uterine Neoplasms / Q000188:drug therapy
D000970:Antineoplastic Agents
Interne Karzinombehandlung mit dem Zytostatikum Proresid.